Bruce N. Jacobs - Dec 3, 2021 Form 4 Insider Report for Kymera Therapeutics, Inc. (KYMR)

Role
Chief Financial Officer
Signature
/s/ Bruce N. Jacobs
Stock symbol
KYMR
Transactions as of
Dec 3, 2021
Transactions value $
-$514,837
Form type
4
Date filed
12/3/2021, 05:43 PM
Previous filing
Nov 23, 2021
Next filing
Jan 14, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction KYMR Common Stock Options Exercise $20.8K +10K +57.1% $2.08* 27.5K Dec 3, 2021 Direct F1
transaction KYMR Common Stock Sale -$411K -7.71K -28.03% $53.31 19.8K Dec 3, 2021 Direct F2, F3
transaction KYMR Common Stock Sale -$108K -1.99K -10.03% $54.32 17.8K Dec 3, 2021 Direct F2, F4
transaction KYMR Common Stock Sale -$16.5K -300 -1.68% $55.07 17.5K Dec 3, 2021 Direct F2, F5

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction KYMR Stock Option (Right to Buy) Options Exercise $0 -10K -5% $0.00 190K Dec 3, 2021 Common Stock 10K $2.08 Direct F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This number includes 258 shares acquired under the Registrant's employee stock purchase plan on November 30, 2021.
F2 This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 6, 2020.
F3 The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $52.91 to $53.88. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
F4 The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $53.92 to $54.74. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
F5 The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $54.96 to $55.12. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
F6 Twenty-five percent (25%) of the shares underlying this stock option vested on July 1, 2020 and the remaining shares shall vest in equal monthly installments over the remaining thirty-six (36) months, subject to the reporting person's continued employment through each vesting date.